Showing results (281-290 of 1,098) with videos related to
Sort By:
Pageof 110
BMJ Open Diabetes Research & Care|July 5, 2022
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuriaJanet B McGill, Hermann Haller, Prabir Roy-Chaudhury, et al.Journal of Diabetes Research|September 6, 2019
Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of DiabetesYanai Wang, Ying Gao, Xiaoling Cai, et al.Frontiers in Endocrinology|November 14, 2018
Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in ChinaGuangxu Liu, Jingtao Dou, Yuesong Pan, et al.Expert Opinion on Pharmacotherapy|February 17, 2023
The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysisRuoyang Jiao, Chu Lin, Shuzhen Bai, et al.Journal of Evidence-Based Medicine|September 19, 2024
The association between the eGFR slope and cardiorenal prognosis in patients with renoprotective treatments: A systematic review and meta-analysisShuzhen Bai, Chu Lin, Xiaoling Cai, et al.Frontiers in Clinical Diabetes and Healthcare|June 16, 2023
The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional surveyLingli Zhou, Yingying Luo, Yan Wang, et al.Clinical Therapeutics|January 1, 2014
Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III studyLinong Ji, Jianhua Ma, Hongmei Li, et al.Diabetes, Obesity & Metabolism|January 12, 2017
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trialLinong Ji, Ling Li, Jian Kuang, et al.JAMA|June 7, 2026
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical TrialLeili Gao, Hongwei Jiang, Hanqing Cai, et al.Nature Communications|December 13, 2023
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesityLinong Ji, Hongwei Jiang, Zhifeng Cheng, et al.Pageof 110